Format
Sort by

Send to

Choose Destination

Search results

Items: 18

1.

Intensive versus conventional glucose control in critically ill patients with traumatic brain injury: long-term follow-up of a subgroup of patients from the NICE-SUGAR study.

NICE-SUGAR Study Investigators for the Australian and New Zealand Intensive Care Society Clinical Trials Group and the Canadian Critical Care Trials Group, Finfer S, Chittock D, Li Y, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Hebert P, Henderson W, Heyland D, Higgins A, McArthur C, Mitchell I, Myburgh J, Robinson B, Ronco J.

Intensive Care Med. 2015 Jun;41(6):1037-47. doi: 10.1007/s00134-015-3757-6. Epub 2015 Jun 19.

PMID:
26088909
2.

Goal-directed resuscitation for patients with early septic shock.

ARISE Investigators; ANZICS Clinical Trials Group, Peake SL, Delaney A, Bailey M, Bellomo R, Cameron PA, Cooper DJ, Higgins AM, Holdgate A, Howe BD, Webb SA, Williams P.

N Engl J Med. 2014 Oct 16;371(16):1496-506. doi: 10.1056/NEJMoa1404380. Epub 2014 Oct 1.

3.

Australasian Resuscitation In Sepsis Evaluation trial statistical analysis plan.

Delaney A, Peake SL, Bellomo R, Cameron P, Holdgate A, Howe B, Higgins A, Presneill J, Webb S; ARISE Investigators.

Emerg Med Australas. 2013 Oct;25(5):406-15. doi: 10.1111/1742-6723.12116. Epub 2013 Sep 9.

PMID:
24099368
4.

The Australasian Resuscitation in Sepsis Evaluation (ARISE) trial statistical analysis plan.

Delaney AP, Peake SL, Bellomo R, Cameron P, Holdgate A, Howe B, Higgins A, Presneill J, Webb S; ARISE investigators.

Crit Care Resusc. 2013 Sep;15(3):162-71. Review.

PMID:
23944201
5.

Critical care services and the H1N1 (2009) influenza epidemic in Australia and New Zealand in 2010: the impact of the second winter epidemic.

ANZIC Influenza Investigators, Webb SA, Aubron C, Bailey M, Bellomo R, Howe B, McArthur C, Morrison S, Seppelt I.

Crit Care. 2011 Jun 9;15(3):R143. doi: 10.1186/cc10266.

6.

Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the Gardos channel blocker senicapoc (ICA-17043).

Ataga KI, Reid M, Ballas SK, Yasin Z, Bigelow C, James LS, Smith WR, Galacteros F, Kutlar A, Hull JH, Stocker JW; ICA-17043-10 Study Investigators.

Br J Haematol. 2011 Apr;153(1):92-104. doi: 10.1111/j.1365-2141.2010.08520.x. Epub 2011 Feb 17.

PMID:
21323872
7.

Enteral feed obstructing its own way.

Kesarwani V, Ghelani DR, Reece G.

Indian J Crit Care Med. 2010 Jul;14(3):141-3. doi: 10.4103/0972-5229.74172.

8.

Hepatic portal venous gas: a case report and review of literature.

Kesarwani V, Ghelani DR, Reece G.

Indian J Crit Care Med. 2009 Apr-Jun;13(2):99-102. doi: 10.4103/0972-5229.56058.

9.

Critical care services and 2009 H1N1 influenza in Australia and New Zealand.

ANZIC Influenza Investigators, Webb SA, Pettilä V, Seppelt I, Bellomo R, Bailey M, Cooper DJ, Cretikos M, Davies AR, Finfer S, Harrigan PW, Hart GK, Howe B, Iredell JR, McArthur C, Mitchell I, Morrison S, Nichol AD, Paterson DL, Peake S, Richards B, Stephens D, Turner A, Yung M.

N Engl J Med. 2009 Nov 12;361(20):1925-34. doi: 10.1056/NEJMoa0908481. Epub 2009 Oct 8.

10.

Long-term survival of intensive care and hospital patient cohorts compared with the general Australian population: a relative survival approach.

Ghelani D, Moran JL, Sloggett A, Leeson RJ, Peake SL.

J Eval Clin Pract. 2009 Jun;15(3):425-35. doi: 10.1111/j.1365-2753.2008.01030.x. Epub 2009 Apr 2.

PMID:
19366395
11.

Intensive versus conventional glucose control in critically ill patients.

NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, HĂ©bert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ.

N Engl J Med. 2009 Mar 26;360(13):1283-97. doi: 10.1056/NEJMoa0810625. Epub 2009 Mar 24.

12.
13.

The effect of obesity on 12-month survival following admission to intensive care: a prospective study.

Peake SL, Moran JL, Ghelani DR, Lloyd AJ, Walker MJ.

Crit Care Med. 2006 Dec;34(12):2929-39.

PMID:
17075374
14.

Protection of endothelial survival by peroxisome proliferator-activated receptor-delta mediated 14-3-3 upregulation.

Liou JY, Lee S, Ghelani D, Matijevic-Aleksic N, Wu KK.

Arterioscler Thromb Vasc Biol. 2006 Jul;26(7):1481-7. Epub 2006 Apr 27.

15.

Secondary malignancies after hematopoietic stem cell transplantation.

Ghelani D, Saliba R, Lima Md.

Crit Rev Oncol Hematol. 2005 Oct;56(1):115-26. Review.

PMID:
15979325
16.

Diagnostic significance of immunoglobulins and adenosine deaminase in pleural effusion.

Ghelani DR, Parikh FS, Hakim AS, Pai-Dhungat JV.

J Assoc Physicians India. 1999 Aug;47(8):787-90.

PMID:
10778623
17.

Methylphenidate: diurnal effects on locomotor and stereotypic behavior in the rat.

Gaytan O, Ghelani D, Martin S, Swann A, Dafny N.

Brain Res. 1997 Nov 28;777(1-2):1-12.

PMID:
9449407
18.

Dose response characteristics of methylphenidate on different indices of rats' locomotor activity at the beginning of the dark cycle.

Gaytan O, Ghelani D, Martin S, Swann A, Dafny N.

Brain Res. 1996 Jul 15;727(1-2):13-21.

PMID:
8842378
Items per page

Supplemental Content

Loading ...
Write to the Help Desk